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Sir,
Stroke-related impairments and inactivity contribute to 
the accelerated development of bone mass removal.[1-3] 
However, the extent of decrease in bone mineral density 
(BMD) after stroke and all factors that influence such rapid 
bone loss are still not sufficiently explored. The purpose of 
this study was to determine the extent of BMD reduction 
in patients after stroke and to identify risk factors for 
osteoporosis. 
This research was designed as a cross-sectional study that 
included patients after a first stroke (≤1.5 years from a 
stroke; N = 40), who went through inhospital rehabilitation 
treatment. Data were gathered by the means of anamnesis 
and available medical documentation. Lunar densitometer 
was used to determine BMD. Dual X-ray absorptiometry 
(DXA) examination was performed at the beginning of 
rehabilitation treatment and at a 1-year follow-up. DXA 
measurement was performed by Hologic quantitative digital 
radiography (QDR) (Hologic Deutschland GmbH, Germany) 
4500A densitometer at the lumbar spine L2-L4 segment in 
anteroposterior (AP) position, while the femur was analyzed 
at the femoral neck, trochanter, and Ward’s triangle. Femoral 
BMD was analyzed on the paretic side of the body.
Bone density measurements were reported as g/cm2. T-scores 
(comparison with mean young adult population peak bone 
mass) and Z-scores (comparison with age-matched population 
mean bone mass) were automatically generated from the 
Hologic normative databases; the scores were gender- and 
race-matched. BMD criteria for the diagnosis of osteoporosis 
(BMD T-score <–2.5) and osteopenia (BMD T-score of –1 
to –2.5) were used. Patients who were diagnosed with 
osteopenia and low serum vitamin D levels received vitamin D 
supplementation therapy after initial DXA examination, while 
osteoporotic patients received antiresorptive bone therapy 
(bisphosphonates).
Osteoporosis in patients with stroke: 
A cross-sectional study
For statistical analysis, we used the statistical program 
International Business Machines (IBM) Statistical Package for 
the Social Sciences (SPSS) Statistics 22.0. Results were presented 
using standard statistical measures of central tendency and 
range of results. To determine the difference between variables, 
T-test for independent samples was used.
In this study, most patients were menopausal women 
(82.50%; N = 33). The mean age of patients was 66.5 ± 9.8 
years. The average values of height were 157.62 ± 36.41 cm, 
the average values of weight were 67.15 ± 13.68 kg, and the 
average values of body mass index (BMI) were 25.66 ± 3.98. 
The most prevalent impairment was right-sided hemiparesis 
(65%; N = 26). We also recruited 40 consecutive age- and 
sex-matched healthy subjects who were free from earlier 
fractures, chronic diseases, and medications influencing 
bone metabolism (e.g., glucocorticoids, anticonvulsants, and 
thyroxine). Healthy subjects were selected randomly from 
Figure 1: Comparison between the incidence of osteoporosis in 
stroke patients and in healthy subjects
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applicants for an annual health check in our hospital. For 
age-matching, the stroke patients and the healthy subjects 
were matched by the year of birth. The comparison between 
incidence of osteoporosis in stroke and in healthy subjects 
is shown in Figure 1.
The average length of time elapsed since stroke at the 
moment of initial evaluation was 1.5 ± 0.4 years. One year 
after inhospital rehabilitation, we performed control DXA 
examination in available patients (92.5%; N = 37), because 
two female patients died and one male patient refused control 
examination. 
The most common risk factor for stroke in our research was 
arterial hypertension (41.97%), followed by heart disease 
(35.80%), heredity (9.88%), dyslipidemia, and diabetes 
mellitus (6.17%).
Risk factors for osteoporosis were assessed in this research 
as well. The largest percentage of participants in this study 
consisted of nonsmokers (67.50%). Positive family history for 
fractures was found in 2.50% of the patients. Hip fractures were 
the most common (12.50%), while vertebral fractures were 
present in 5% of patients. In our research, the largest percentage 
of patients used antihypertensive therapy (21.09%), followed 
by antidepressants (12.93%), and statins (6.80%). Only 2.5% of 
the patients were receiving antiresorptive bone therapy and 
vitamin D supplementation at the moment of initial evaluation.
The average value of DXA T-score of the lumbar spine, 
vertebrae L1-L4 at baseline was –1.89 ± 0.69, average value of 
lumbar spine BMD at baseline was 0.986 ± 0.234 [Figure 1]. 
According to the criteria we set, most patients (42.50%; N = 17) 
had osteoporosis of the lumbar spine; preserved BMD was 
found in 13 patients (32.50%), and 10 patients (25%) had 
osteopenia. No significant difference was found between 
the values of lumbar spine BMD and T-score at baseline and 
follow-up examination [Table 1]. To compare BMD values of 
stroke patients with population and age-matched mean bone 
mass, we used Z-score. The average value of DXA Z-score of 
the lumbar spine vertebrae L1-L4 at baseline and at follow-up 
are shown in Table 1.
The average value of T-score of the femur (total) at baseline 
was –1.39 ± 1.18 and the average value of femur BMD at 
baseline was 0.847 ± 0.17. At initial evaluation, preserved 
BMD of the femur was observed in 13 patients (32.50%), while 
most patients had osteopenia (52.50%). The smallest number 
of patients had osteoporosis of the femur (15%). Baseline and 
follow-up values of femur BMD and T-score have shown 
no significant difference. Z-score values of femur total are 
shown in Table 1. 
We also analyzed DXA T-scores of the femoral neck: 52.5% of 
patients had femoral neck osteopenia, 15.0% had osteoporosis, 
while 32.5% had preserved BMD. The values of femoral neck 
BMD, T-score, and Z-score did not significantly differ between 
initial evaluation and follow-up [Table 1]. In our research, we 
found no statistically significant difference in mean BMD and 
T-score between left and right femur. However, statistically 
significant difference in mean T-score at the femoral neck was 
found between the left and right sided hemiparetic patients 
(P < 0.001) [Table 2].
Results from epidemiological studies indicate an association 
between cerebrovascular (CV) disease and osteoporosis.[4,5] In 
our research, 42.50% of the stroke patients had osteoporosis of 
the lumbar spine and 15% had osteoporosis of the femur that 
further strengthens the hypothesis of a possible relationship 
between CV disease and osteoporosis. The results of our 
study show that despite the fact that the majority of patients 
after stroke have osteopenia or osteoporosis, a very small 
number of them receives treatment for the prevention of 
decreased BMD. Our results also demonstrate that there was 
a slight decrease in the values of BMD, T-scores, and Z-scores 
at a 12-month follow-up, but no statistically significant 
difference was found between those and initial values. This 
may imply that physical therapy, vitamin D supplementation, 
and antiresorptive bone therapy prevented further significant 
bone loss in poststroke patients, but further research is 
needed to confirm this hypothesis. Our study provides 
additional evidence that the reduction in BMD is one of the 
major complications of a stroke. Given that the incidence of 
fractures in this population is large, there is a need to perform 
routine DXA examinations.
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Table 1: Comparison between BMD, T-score, and 
Z-score at initial evaluation (baseline) and 12-month 
follow-up
Baseline 12-month follow-up P
BMD
Lumbar spine 0.986±0.234 0.891±0.356 0.167
Total hip 0.847±0.171 0.756±0.451 0.238
Femoral neck 0.751±0.213 0.635±0.561 0.228
T-score
Lumbar spine −1.89±0.69 −1,97±0.34 0.526
Total hip −1.39±1.18 −1.51±0.76 0.601
Femoral neck −2.34±0.82 −2.49±1.23 0.528
Z-score
Lumbar spine −0.63±0.52 −0.87±0.89 0.149
Total hip −0.31±1.05 −0.45±0.78 0.511
Femoral neck −0.97±1.03 −0.82±1.14 0.546
Table 2: Comparison between mean values of DXA, 
BMD, and T-score of the femoral neck and femur total in 
left and right hemiparetic stroke patients
Hemiparetic 
side
Femur total Femur neck
T-score BMD T-score BMD
Right side (N=26) −1.7±0.82 0.802±0.122 −2.7±0.63 0.738±0.316
Left side (N=14) −1.3±1.07 0.860±0.230 −1.6±1.07 0.804±0.161
P 0.034 0.193 0.001* 0.195
*P < 0.05 significant
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Sir,
We wish to describe a rare case of autoimmune necrotizing 
myopathy (ANM) in a patient who was admitted to our 
hospital recently. She had a subacute myopathy with 
weight loss and cardiac involvement. Blood levels of 
creatine kinase (CK) and a muscle biopsy clinched the 
diagnosis of this potentially treatable condition and she 
responded to treatment. As necrotizing autoimmune 
myopathy is a rare and potentially treatable myopathy 
with only 300 cases reported worldwide, we are describing 
her case below.
A 17-year-old girl presented with history of intermittent 
fever of 2 months duration followed by myalgia, walking 
difficulty, weakness, loss of appetite, and vomiting. 
There was no history of any intake of statins, indigenous 
drugs, or any medication prior to this illness. There was 
no history of skin rashes, oral ulcers, photosensitivity, 
alopecia, polyarthritis, loss of weight or any malignancy 
prior to this illness or any malignancy prior to this illness. 
There was no history of exanthematous rash, conjunctivitis, 
jaundice, allergic rhinitis, cough or urticaria. She was mostly 
confined to bed by the time she presented to us. On initial 
examination, the patient was thin-built, her temperature was 
100.4°F, pulse was 100/min, and blood pressure (BP) was 
Necrotizing autoimmune myopathy
120/80 mmHg. There was no skin rash, jaundice, oral ulcer, 
lymphadenopathy, polyarthritis, or hepatosplenomegaly. 
Cardiovascular (CVS) system, respiratory system, and 
examination of the abdomen were normal. Local examination 
revealed tenderness in the anterior and lateral aspects of 
both the thighs.
On neurological examination, the higher mental functions and 
cranial nerves were normal. On motor system examination, 
there was muscle tenderness with grade 3/5 power in all muscles 
of the bilateral lower limbs. Initial investigations revealed 
elevated CK levels (1,660 IU/L) with polymorphonuclear 
leukocytosis [total leukocyte count (TLC) 12,200/mm3] and 
raised C-reactive protein (CRP) levels. X-ray of the chest 
and ultrasound (USG) of the whole abdomen were normal. 
Viral antibody screening for human immunodeficiency virus 
(HIV), hepatitis B surface antigen (HBs Ag), hepatitis C virus 
(HCV), and dengue virus was negative. Autoantibody tests 
such as antinuclear antibody (ANA), anti-doubled stranded 
(ds)DNA, c-antineutrophil cytoplasmic antibody (ANCA), 
p-ANCA, and ANA profile including antisynthetase antibody 
were negative. Anti-signal recognition particle (SRP) and 
anti-HMG-CoA antibody antibodies were not tested due 
to nonavailablity of tests in our laboratory. Moreover, 
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